iRadimed Corporation (NASDAQ: IRMD) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT IRADIMED CORPORATION

iRadimed Corporation (NASDAQ: IRMD)
Listen to this Section


$62.67
+1.4400 ( +1.31% ) 23.1K

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Market Data


Open $62.67
Previous Close $61.23
Volume 23.1K
Market Cap $786.39M
Day Range $61.36 - $62.92
52 Week Range $40.18 - $62.92
Shares Outstanding 12.67M
Change % +1.31%
Net Change ▲ 1.4400
Insider Ownership 0.00%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2014
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -449,004.00

Date Type Amount Purchased Purchaser
2024-06-04 Sale -1947.00 ALLEN MONTY K
2023-12-27 Sale -5000.00 Susi Roger E.
2023-12-22 Sale -300000.00 Susi Roger E.
2023-12-20 Sale -5000.00 Susi Roger E.
2023-12-14 Sale -468.00 HAWKINS JAMES B
2023-12-13 Sale -5000.00 Susi Roger E.
2023-12-11 Sale -1036.00 ALLEN MONTY K
2023-12-11 Sale -7180.00 GLENN JOHN
2023-12-11 Sale -2393.00 Scharen-Guivel Hilda Frederique
2023-12-11 Sale -1036.00 VUOTO ANTHONY

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Dec 10, 2024
3 Insider transactions 2 Dec 06, 2024
4 Insider transactions 1 Dec 02, 2024
4 Insider transactions 1 Nov 06, 2024
8-k 8K-related 15 Oct 31, 2024
10-q Quarterly Reports 66 Oct 31, 2024
4 Insider transactions 1 Oct 15, 2024
8-k 8K-related 15 Aug 01, 2024
10-q Quarterly Reports 66 Aug 01, 2024
8-k 8K-related 14 Jun 20, 2024

Latest News


× Before browsing our site, please accept our cookies policy